MedPath

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Phase 3
Completed
Conditions
Overactive Bladder
Registration Number
NCT00131573
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
118
Inclusion Criteria

Not provided

Exclusion Criteria
  • Have any active implantable device regardless of whether stimulation status is ON or OFF.
  • Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period.
  • Less than one year post partum and/or are breast-feeding.
  • Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement).
  • Have conditions requiring magnetic resonance imaging (MRI) evaluation.
  • Have conditions requiring diathermy procedures.
  • Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.
  • Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.
  • Have history of coagulopathy or bleeding disorder.
  • Have pelvic pain in the absence of voiding dysfunction.
  • Have anatomical restrictions such that the study device placement is not possible.
  • Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.
  • Cannot independently comprehend and complete the questionnaires.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Average Number of Voids Per Day12 months
Freedom From Major Complications5 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

Arizona Health Sciences Center

🇺🇸

Tucson, Arizona, United States

The Department of Urology, Stanford University Medical Center

🇺🇸

Stanford, California, United States

Milestone Medical Research

🇺🇸

Englewood, Colorado, United States

Walter Reed Army Medical Center

🇺🇸

Washington, District of Columbia, United States

Overland Park Regional Medical Center

🇺🇸

Overland Park, Kansas, United States

William Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Cornerstone Medical Specialty Center

🇺🇸

Woodbury, Minnesota, United States

New York University

🇺🇸

New York, New York, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

The Pelvic and Sexual Health Institute

🇺🇸

Philadelphia, Pennsylvania, United States

Scroll for more (1 remaining)
Arizona Health Sciences Center
🇺🇸Tucson, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.